ClinicalTrials.Veeva

Menu

Fetal Heart Rate Variability

University of Aarhus logo

University of Aarhus

Status

Completed

Conditions

Fetal Growth Retardation

Treatments

Diagnostic Test: fetal heart rate variability

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Need statement

  • a new way to distinguish between a healthy small fetus and a small fetus suffering from deprivation of nutrition and oxygen to prevent unnecessary induction of preterm birth and improve neonatal outcome.

Aim - to characterize fetal heart rate variability (fHRV) based on fetal ECG in the normal fetus and in the fetus suffering from growth retardation to evaluate its value and applicability as a supplementary tool in fetal surveillance.

Aim of current study

  • To evaluate the feasibility of NI-FECG from gestational week 20 and onwards and investigate if important factors as length and heart rate pattern affects repeatability of time domain and spectral analyses in fetuses.

Enrollment

75 patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

• Healthy singleton pregnancies

Exclusion criteria

• Fetal malformations, multiple pregnancy, obstetric complications, maternal chronic disease and labor.

Trial design

75 participants in 1 patient group

Study 2. Repeatability of FHRV
Treatment:
Diagnostic Test: fetal heart rate variability

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems